Nuzenio

Monopar Therapeutics

Monopar Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Monopar Therapeutics (NASDAQ:MNPR) Upgraded at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:17:05 GMTMonopar Therapeutics (NASDAQ:MNPR) Sets New 1-Year High - What's Next? - MarketBeatMarketBeat · Thu, 06 Aug 2026 15:11:03 GMTMNPR Q2'26 Earnings: EPS estimate is (0.66) USD - TradingViewTradingView · Wed, 05 Aug 2026 11:01:22 GMTMonopar Therapeutics Inc (MNPR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKeyTradingKey · Mon, 27 Jul 2026 16:16:43 GMT

Timeline

Sat, 08 Aug 2026 06:17:05 GMTMonopar Therapeutics (NASDAQ:MNPR) Upgraded at Wall Street Zen - MarketBeat
Thu, 06 Aug 2026 15:11:03 GMTMonopar Therapeutics (NASDAQ:MNPR) Sets New 1-Year High - What's Next? - MarketBeat
Wed, 05 Aug 2026 11:01:22 GMTMNPR Q2'26 Earnings: EPS estimate is (0.66) USD - TradingView
Mon, 27 Jul 2026 16:16:43 GMTMonopar Therapeutics Inc (MNPR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Monopar Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.